Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 29 (2) , 179-191
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 40 references indexed in Scilit:
- Generalizability of Epidemiological Findings and Public Health Decisions: An Illustration From the Rochester Epidemiology ProjectMayo Clinic Proceedings, 2012
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Normal Cognitive AgingArchives of General Psychiatry, 2008
- The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample CharacteristicsNeuroepidemiology, 2008
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBrain, 2008
- Chronic distress and incidence of mild cognitive impairmentNeurology, 2007
- Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PETNeuroImage, 2002
- Mayo's Older Americans Normative Studies: Category Fluency NormsJournal of Clinical and Experimental Neuropsychology, 1998
- Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diseaseAnnals of Neurology, 1997
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987